Drug intelligence / Profile preview

carbenicillin

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Carbenicillin is a semi-synthetic, bactericidal antibiotic belonging to the carboxypenicillin subgroup of the penicillins. It was discovered by scientists at Beecham and marketed under brand names such as Geocillin and Pyopen. Carbenicillin is primarily used to treat acute and chronic infections of the urinary tract caused by susceptible Gram-negative bacteria, notably including *Pseudomonas aeruginosa*, *Escherichia coli*, *Proteus* species, *Morganella morganii*, *Providencia rettgeri*, *Enterobacter* species, and *Enterococcus faecalis*. Its mechanism of action involves inhibition of bacterial cell wall synthesis through acylation of penicillin-sensitive transpeptidase enzymes (penicillin-binding proteins), thereby preventing cross-linking in peptidoglycan strands essential for cell wall integrity. This leads to bacterial cell lysis mediated by autolytic enzymes[1][2][5]. Carbenicillin has limited Gram-positive coverage compared to other penicillins but is notable for its antipseudomonal activity[5]. It is acid-labile but more stable than ampicillin at lower pH[5].

Brand names
GeocillinPyopen
Other names
carbenicillin indanyl sodium
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on carbenicillin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carbenicillin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call